Paul Segal - 10 May 2023 Form 4 Insider Report for Alphatec Holdings, Inc. (ATEC)

Role: 10%+ Owner
Signature: /s/ Paul Segal
Issuer symbol: ATEC
Transactions as of: 10 May 2023
Net transactions value: -$2,492,340
Form type: 4
Filing time: 12 May 2023, 16:59:29 UTC
Previous filing: 16 Jun 2022
Next filing: 22 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATEC	Common Stock	Sale	$2,492,340	-167,496	-49%	$14.88	171,329	10 May 2023	Direct	F1
holding	ATEC	Common Stock						11,081,538	10 May 2023	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging $14.88 to $15.67, inclusive. The reporting undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2	Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

Content

This price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging $14.88 to $15.67, inclusive. The reporting undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.